TrialThe international journal of neuropsychopharmacology2022

Efficacy, Safety, and Tolerability of Ansofaxine (LY03005) Extended-Release Tablet for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding, Phase 2 Clinical Trial.

Weifeng Mi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.